• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α.

作者信息

Onishi Sachiko, Yoshio Taku, Nagashima Takao, Minota Seiji

出版信息

Mod Rheumatol. 2010 Oct;20(5):528-30. doi: 10.1007/s10165-010-0305-7. Epub 2010 May 12.

DOI:10.1007/s10165-010-0305-7
PMID:20458607
Abstract
摘要

相似文献

1
Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α.对抗肿瘤坏死因子-α有反应的日本类风湿性关节炎患者中抗环瓜氨酸肽抗体水平的降低
Mod Rheumatol. 2010 Oct;20(5):528-30. doi: 10.1007/s10165-010-0305-7. Epub 2010 May 12.
2
The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.依那西普对类风湿关节炎患者抗环瓜氨酸肽抗体及类风湿因子的影响。
Ann Rheum Dis. 2006 Jan;65(1):35-9. doi: 10.1136/ard.2005.038851. Epub 2005 Jun 23.
3
High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis.高IgA类风湿因子水平与类风湿关节炎患者对肿瘤坏死因子α抑制剂的临床反应不佳相关。
Ann Rheum Dis. 2007 Mar;66(3):302-7. doi: 10.1136/ard.2006.060608. Epub 2006 Nov 1.
4
[Correlation between different clinical activity and anti CC-P (anti-cyclic citrullinated peptide antibodies) titres in rheumatoid arthritis treated with three different tumor necrosis factors TNF-alpha blockers].[三种不同肿瘤坏死因子α阻滞剂治疗类风湿关节炎时不同临床活动度与抗环瓜氨酸肽（anti-cyclic citrullinated peptide antibodies，抗CC-P）抗体滴度之间的相关性]
Recenti Prog Med. 2006 Mar;97(3):134-9.
5
Efficacy of rituximab in patients with rheumatoid arthritis refractory or with contra-indication to anti-tumor necrosis factor-alpha drugs in daily practice: an open label observational study.利妥昔单抗在日常实践中对难治性类风湿关节炎患者或对抗肿瘤坏死因子-α药物有禁忌证患者的疗效：一项开放标签观察性研究。
Clin Exp Rheumatol. 2007 May-Jun;25(3):504.
6
Antibodies against mutated citrullinated vimentin fail to predict anti-TNFalpha treatment response in rheumatoid arthritis.抗突变瓜氨酸波形蛋白抗体无法预测类风湿关节炎患者对肿瘤坏死因子α拮抗剂治疗的反应。
Scand J Rheumatol. 2009 Jan-Feb;38(1):66-7. doi: 10.1080/03009740802220067.
7
[Therapy of rheumatoid arthritis with etanercept].用依那西普治疗类风湿关节炎
Internist (Berl). 2009 May;50(5):633-4. doi: 10.1007/s00108-009-2378-y.
8
Etanercept improves rheumatoid arthritis partially responsive to methotrexate.依那西普可改善对甲氨蝶呤部分反应性的类风湿性关节炎。
Clin Exp Rheumatol. 2001 Nov-Dec;19(6):626-7.
9
Increased adiponectin levels in women with rheumatoid arthritis after etanercept treatment.类风湿关节炎女性患者接受依那西普治疗后脂联素水平升高。
J Rheumatol. 2009 Jun;36(6):1346-7; author reply 1347. doi: 10.3899/jrheum.081192.
10
Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.利妥昔单抗与抗肿瘤坏死因子-α阻滞剂联合治疗成功治愈严重难治性类风湿关节炎。
J Rheumatol. 2009 Sep;36(9):2125-6. doi: 10.3899/jrheum.090160.

引用本文的文献

1
Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.TNF 抑制剂与免疫球蛋白片段结晶区（Fc）在类风湿关节炎中的疗效差异：ANSWER 队列研究。
Rheumatol Int. 2022 Jul;42(7):1227-1234. doi: 10.1007/s00296-021-05086-w. Epub 2022 Mar 10.
2
Autoantibodies as Diagnostic Markers and Mediator of Joint Inflammation in Arthritis.自身抗体作为关节炎关节炎症的诊断标志物和介质。
Mediators Inflamm. 2019 Oct 27;2019:6363086. doi: 10.1155/2019/6363086. eCollection 2019.
3
Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review.
抗瓜氨酸化肽抗体及其预测生物制剂反应的价值：综述
Rheumatol Int. 2016 Aug;36(8):1043-63. doi: 10.1007/s00296-016-3506-3. Epub 2016 Jun 6.
4
Clinical parameters and biomarkers for anti-TNF treatment prognosis in rheumatoid arthritis patients.类风湿关节炎患者抗TNF治疗预后的临床参数和生物标志物
Clin Rheumatol. 2014 Dec;33(12):1707-14. doi: 10.1007/s10067-014-2756-2. Epub 2014 Aug 2.